BioWorld

Nov. 7, 2003

Climbing Through The Window: Pharmion, NitroMed Price IPOs

The industry increased its number of publicly traded companies Thursday as Pharmion Corp. and NitroMed Inc. priced their initial public offerings. (BioWorld Today) Read More

Telik Raises $130M To Support Telcyta, Telintra Clinical Trials

Sequenom Discovers Genetic Markers Tied To Breast Cancer

As Entereg Nears Filing, Adolor Raises $103.5M Via Public Sale

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for Aug. 29, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Aug. 29, 2025.

Sideroflexin 1 is potential therapeutic target in bladder cancer

BioWorld Science

Bladder cancer is among the 10 most frequent cancers around the world. While potentially effective treatments exist, they do not benefit all patients, so...

Industry looking to adapt under shadow of US Rx tariffs

BioWorld

While U.S. President Donald Trump’s country-by-country reciprocal and newly negotiated tariffs go into effect today, a separate, global biopharma sector tariff...

Serum α-1-microglobulin is biomarker in aortic valve stenosis

BioWorld Science

Calcific aortic valve disease (CAVD) is the most prevalent acquired valve heart disorder in aging populations. Its most severe form in aortic valve stenosis...